tetano
Editor, Senior Moderator
Hum Vaccin Immunother. 2018 Feb 16:1-19. doi: 10.1080/21645515.2018.1440162. [Epub ahead of print]
[h=1]Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic.[/h] Lehnert JD[SUP]1,[/SUP][SUP]2[/SUP], Shevach A[SUP]2,[/SUP][SUP]3[/SUP], Walker S[SUP]4,[/SUP][SUP]5[/SUP], Wang R[SUP]5[/SUP], Fitzgerald TJ[SUP]1,[/SUP][SUP]2[/SUP], Graitcer SB[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In an influenza pandemic, two vaccine doses administered 21 days apart may be needed for individuals of all ages to achieve seroprotection. Achieving dose-series completion can be challenging even for routinely recommended vaccines. To prepare for a two-dose influenza pandemic vaccine campaign and promote dose-series completion and correct dosing intervals, CDC and its partners developed a text message-based vaccine reminder system to remind persons who receive a first dose of pandemic influenza vaccine to receive the second dose. Taking advantage of the high prevalence of cell phones in the United States, the system sent second-dose text message reminders and hyperlinks to educational information. The system was pilot tested from November 2015 to April 2016 among graduate public health students enrolled at four United States universities. Universities were selected based on convenience, and each university used a different recruitment method. Among 59 volunteers who pilot tested the system and completed a survey, 57 (92%) felt the system would be helpful during a pandemic. Forty (68%) respondents felt the information included in the messages was informative. Volunteers recommended including actionable ways to stay healthy during a pandemic, though specific suggestions varied. With further development, text reminder systems could be used to promote adherence to a two-dose regimen in a future pandemic, although audience-specific messaging and other complementary systems will likely be needed. Public and private partners can adapt and implement this tool in conjunction with their routine patient information systems to improve dose-series completion and ensure optimal protection during an influenza pandemic.
PMID: 29451833 DOI: 10.1080/21645515.2018.1440162
[h=1]Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic.[/h] Lehnert JD[SUP]1,[/SUP][SUP]2[/SUP], Shevach A[SUP]2,[/SUP][SUP]3[/SUP], Walker S[SUP]4,[/SUP][SUP]5[/SUP], Wang R[SUP]5[/SUP], Fitzgerald TJ[SUP]1,[/SUP][SUP]2[/SUP], Graitcer SB[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In an influenza pandemic, two vaccine doses administered 21 days apart may be needed for individuals of all ages to achieve seroprotection. Achieving dose-series completion can be challenging even for routinely recommended vaccines. To prepare for a two-dose influenza pandemic vaccine campaign and promote dose-series completion and correct dosing intervals, CDC and its partners developed a text message-based vaccine reminder system to remind persons who receive a first dose of pandemic influenza vaccine to receive the second dose. Taking advantage of the high prevalence of cell phones in the United States, the system sent second-dose text message reminders and hyperlinks to educational information. The system was pilot tested from November 2015 to April 2016 among graduate public health students enrolled at four United States universities. Universities were selected based on convenience, and each university used a different recruitment method. Among 59 volunteers who pilot tested the system and completed a survey, 57 (92%) felt the system would be helpful during a pandemic. Forty (68%) respondents felt the information included in the messages was informative. Volunteers recommended including actionable ways to stay healthy during a pandemic, though specific suggestions varied. With further development, text reminder systems could be used to promote adherence to a two-dose regimen in a future pandemic, although audience-specific messaging and other complementary systems will likely be needed. Public and private partners can adapt and implement this tool in conjunction with their routine patient information systems to improve dose-series completion and ensure optimal protection during an influenza pandemic.
PMID: 29451833 DOI: 10.1080/21645515.2018.1440162